&agr;aminocetic acid derivatives- &agr;4&bgr;7 receptor antagonists
    3.
    发明授权
    &agr;aminocetic acid derivatives- &agr;4&bgr;7 receptor antagonists 失效
    α-氨基酸衍生物-α4β7受体拮抗剂

    公开(公告)号:US06545160B2

    公开(公告)日:2003-04-08

    申请号:US10147884

    申请日:2002-05-20

    IPC分类号: C07D26306

    摘要: Disclosed are compounds which bind &agr;4&bgr;7 integrin. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by &agr;4&bgr;7 integrin. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

    摘要翻译: 公开了结合α4β7整联蛋白的化合物。 这些化合物中的某些也抑制白细胞粘附,特别是由α4β7整联蛋白介导的白细胞粘附。 这样的化合物可用于治疗哺乳动物患者,例如人类例如哮喘,阿尔茨海默氏病,动脉粥样硬化,艾滋病痴呆,糖尿病,炎性肠病,类风湿性关节炎,组织移植,肿瘤转移和心肌缺血等炎性疾病。 化合物也可以用于治疗炎性脑疾病如多发性硬化症。